<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1579">
  <stage>Registered</stage>
  <submitdate>30/05/2007</submitdate>
  <approvaldate>30/05/2007</approvaldate>
  <nctid>NCT00481416</nctid>
  <trial_identification>
    <studytitle>Evaluation of the PillCamESO Capsule in the Detection of Esophageal Varices</studytitle>
    <scientifictitle>Evaluation of the PillCam Eso Capsule in the Detection of Esophageal Varices</scientifictitle>
    <utrn />
    <trialacronym>MA-37</trialacronym>
    <secondaryid>MA-37</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Esophageal Varices</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - PillCam Eso

Treatment: devices: PillCam Eso


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes />
  <eligibility>
    <inclusivecriteria>1. Patient has prior endoscopic confirmation of esophageal varices and is undergoing
             surveillance endoscopy or

          2. Patient has sign/symptoms of chronic liver disease, without previous diagnosis of
             esophageal varices,with clinical indication to undergo esophagoscopy (or EGD)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient has difficulty swallowing

          2. Patient has known Zenker's Diverticulum

          3. Patient went through previous endoscopic treatment of esophageal varices

          4. Patient is known or is suspected to suffer from intestinal obstruction

          5. Patient has a cardiac pacemaker or other implanted electro medical device

          6. Female patient is pregnant

          7. Patient is expected to undergo MRI examination within 7 days after ingestion of the
             capsule

          8. Patient has had a prior abdominal surgery of the gastrointestinal tract (other than
             uncomplicated appendectomy or uncomplicated cholecystectomy)

          9. Patient has any condition, which precludes compliance with study and/or device
             instructions

         10. Patient suffers from life threatening conditions

         11. Patient is currently participating in another clinical study -</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose>Screening</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration>Cross-sectional</duration>
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/12/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>318</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/01/2005</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Royal Brisbane and Women's Hospital - Herston</hospital>
    <postcode>4029 - Herston</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oregon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Haifa</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Given Imaging Ltd.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Ethicon Endo-Surgery</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to access the accuracy of the PillCam Eso capsule in identifying
      the presence of suspected esophageal disease in patients undergoing surveillance or screening
      for esophageal disease by standard endoscopy</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00481416</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Glenn M Eisen, MD</name>
      <address>OHSU Portland, OR</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>